Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Tharimmune ( (THAR) ) has issued an update.
On October 1, 2025, Tharimmune, Inc. amended its warrants agreement with holders to allow the immediate exercise of warrants for 3,408,110 shares of common stock. This strategic move could enhance liquidity and potentially strengthen the company’s financial position, impacting its market operations and stakeholders positively.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 9,986,232
Technical Sentiment Signal: Hold
Current Market Cap: $16.02M
For an in-depth examination of THAR stock, go to TipRanks’ Overview page.